Tokyo, March 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061075) titled 'Evaluation of Circulating Tumor DNA Analysis and Biomarker Associations for Recurrence Risk After Curative Treatment of Resectable Solid Tumors' on March 30.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Colorectal cancer/Ovarian cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To evaluate the performance of ctDNA analysis using an assay developed by Personalis, Inc. in predicting recurrence and prognosis in patients with solid tumors who have undergone curative-intent treatment
Basic...